DN tissues; renal tissues; serum
-
ceRNA regulation (other); angiogenesis (other); lipid metabolism (other); fibrosis (other)
RT-qPCR; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis
Serum circXPNPEP3 distinguished patients with DN from controls (AUC 0.8389; sensitivity 70.59%; specificity 86.27%), suggesting it as a non-invasive diagnostic biomarker.
circXPNPEP3 (hsa_circ_0008360), derived from XPNPEP3, is up-regulated in DN kidney tissues and patient serum and shows diagnostic potential (ROC AUC 0.8389). A bioinformatically predicted ceRNA network suggests it may sponge hsa-miR-135b-5p/hsa-miR-135a-3p/hsa-miR-1237-3p and thereby affect downstream genes such as SOX4, CREB5, ZFP36L1, GRAMD1B, and PROM1, potentially contributing to DN progression.
0.459
Diagnostic Roles of circXPNPEP3 as Biomarker for Diabetic Nephropathy.
combined biological and clinical study